You are here:Home-Chemical Inhibitors & Agonists-GPCR-Chemokine Receptor (CCR and CXCR)-GW782415W
GW782415W

Chemical Structure : GW782415W

CAS No.: 408304-25-6

GW782415W (GW782415)

Catalog No.: PC-20731Not For Human Use, Lab Use Only.

GW782415W (GW782415) is a potent, specific CCR3 antagonist, inhibits chemotaxis of human and murine eosinophils pKi of 8.08 and 7.85, respectively.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

GW782415W (GW782415) is a potent, specific CCR3 antagonist, inhibits chemotaxis of human and murine eosinophils pKi of 8.08 and 7.85, respectively.
GW782415W ablates both the early and late phase reactions in a mouse model of allergic conjunctivitis.
Systemic administration of GW782415X reduced spontaneous CNV in JR5558 mice and laser-induced CNV in mouse and primate models in a dose-dependent fashion.

Physicochemical Properties

M.Wt 414.29
Formula C16H21Cl2N7O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

O=C(NCC1=NN(C)N=N1)NC[C@H]2CN(CC3=CC=C(Cl)C(Cl)=C3)CCO2

References

1. Takao Nakamura, et al. Immunol Res. 2005;33(3):213-21.

2. Nori Nagai, et al. Am J Pathol. 2015 Sep;185(9):2534-49.

3. Neda Farahi, et al. J Immunol. 2007 Jul 15;179(2):1264-73.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: